XRAY Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
836.0M
-6.9%
898.0M
+2.0%
880.0M
-8.4%
961.0M
+6.3%
904.0M
Cost of Revenue
393.0M
-3.0%
405.0M
-10.6%
453.0M
-12.5%
518.0M
+11.9%
463.0M
Gross Profit
443.0M
-10.1%
493.0M
+15.5%
427.0M
-3.6%
443.0M
+0.5%
441.0M
Operating Expenses
406.0M
-1.2%
411.0M
-11.0%
462.0M
-20.6%
582.0M
-11.7%
659.0M
R&D
42.0M
-6.7%
45.0M
+2.3%
44.0M
+10.0%
40.0M
+8.1%
37.0M
SG&A
363.0M
-0.3%
364.0M
+3.7%
351.0M
-8.4%
383.0M
+7.9%
355.0M
Operating Income
37.0M
-54.9%
82.0M
+334.3%
-35000000
+74.8%
-139000000
+36.2%
-218000000
EBITDA
120.0M
-29.0%
169.0M
+52.3%
111.0M
-1.8%
113.0M
-19.9%
141.0M
Net Income
-3000000
-108.3%
36.0M
+460.0%
-10000000
+93.1%
-145000000
+66.1%
-428000000
EPS (Basic)
$-0.01
-105.6%
$0.18
+460.0%
$-0.05
+93.2%
$-0.73
+65.9%
$-2.14
EPS (Diluted)
$-0.01
-105.6%
$0.18
+460.0%
$-0.05
+93.2%
$-0.73
+65.9%
$-2.14
Shares (Diluted)
199.2M
-0.6%
200.5M
+0.3%
199.9M
+0.5%
199.0M
-0.3%
199.5M
DENTSPLY SIRONA (XRAY) — Financials